TCI Wealth Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
PVH
WBG
KHLMVGHM
HCIA
TCI Wealth Advisors's XPH Position: Q2 2016 in Review
TCI Wealth Advisors sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2016, closing a stake of 1,820 shares — an estimated $73K sold.
TCI Wealth Advisors first reported a position in XPH in Q1 2016 and held it in 1 quarter. The position peaked at $73K in Q1 2016. 60 funds tracked by Wall St. Rank hold XPH as of Q2 2016.
- TCI Wealth Advisors reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2016 after selling out during the quarter.
- TCI Wealth Advisors sold 1,820 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2016, an estimated $73K.
- TCI Wealth Advisors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2016 and held it in 1 quarter.
- TCI Wealth Advisors's State Street SPDR S&P Pharmaceuticals ETF position peaked at $73K in Q1 2016.
- 60 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2016.
Based on TCI Wealth Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.